The Korea Times close
National
  • Politics
  • Diplomacy
  • Defense
  • Labor & Environment
  • Law & Crime
  • Health & Welfare
  • Embassy
  • Seoul & Provinces
  • Education
  • Foreign Communities
  • Obituaries
  • Multicultural Youth Award
Biz & Tech
  • Auto
  • IT
  • Game
  • Manufacturing
  • Retail & Food
  • Energy
  • Construction
  • Airlines
Finance
  • Policies
  • Economy
  • Markets
  • Banks
  • Non-banks
  • Economic Essay Contest
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to the Editor
Lifestyle
  • Arts
  • Books
  • Travel & Cuisine
  • Trend
  • Fashion
  • Around Town
  • Fortune Telling
Entertainment
  • K-pop
  • K-dramas & Shows
  • Movies
  • Music
  • Performances
  • Asia Model Festival
Sports
  • Football
  • Golf
  • Baseball
  • Other Sports
World
  • Asia Pacific
  • Americas
  • Europe & Africa
  • SCMP
Video
  • On the Spot
  • Feature
  • News
Photos
  • Photo News
  • Darkroom
Community
  • The Korea Times
  • search
  • Site Map
  • E-paper
  • Subscribe
  • Register
  • LogIn
search close
  • The Korea Times
  • search
  • Site Map
  • E-paper
  • Subscribe
  • Register
  • LogIn
search close
Reporter : Nam Hyun-woo
Fri, January 22, 2021 | 02:38
Will Jin Air, Air Busan rebrand as Asiana?
Korean Air's takeover of Asiana Airlines is drawing attention to how the low-cost carrier (LCC) affiliates of the two will be integrated, with industry officials anticipating a merger of the LCCs that will be given the brand name Asiana.
Airlines | 2021-01-21 16:22
SK Bioscience to license in Novavax' COVID-19 vaccine
President Moon Jae-in visited an SK Bioscience plant that will manufacture a COVID-19 vaccine developed by Novavax and discussed ways to expand the supply of Novavax's COVID-19 vaccine to Korea with its CEO. SK Bioscience is a contract manufacturer of Novavax's COVID-19 vaccine.
Health & Welfare | 2021-01-20 16:37
GM Korea, Renault Samsung future uncertain amid EV transition
With electric vehicles (EVs) taking center stage in the global automobile industry, GM Korea and Renault Samsung's future as car manufacturers here is clouded with uncertainty after they failed to win EV production orders from their respective headquarters. During the recent Consumer Electronics Show, General Motors revealed its EV platform, Ultium, and promised that the comp...
Auto | 2021-01-20 09:00
Audi e-tron sales faces setback here over travel range certification
Audi's electric vehicle (EV), the e-tron 55 Quattro, is facing a setback in sales here, as Korea's environment ministry is considering canceling the vehicle's certification over the questionable range it is claimed to be able to travel on a single charge, according to industry officials, Tuesday.
Auto | 2021-01-19 16:35
Hanon Systems appoints new CEO
Hanon Systems has appointed Sung Min-suk as its new CEO, while the company cut the number of its “representative executive officers” from three to two, it said, Monday.
Auto | 2021-01-18 14:53
KSOE eyes over $14.9 billion in new orders this year
Korea Shipbuilding & Offshore Engineering (KSOE), a holding firm of Hyundai Heavy Industries (HHI) and a shipbuilding unit of HHI Group, is expecting to claim more than $14.9 billion in new orders this year, including up to 10 vessels from Qatar Petroleum's LNG project.
Manufacturing | 2021-01-18 13:04
Doosan Group's successful restructuring is now up to Hyundai Heavy
Doosan Group's efforts to sell its construction equipment unit Doosan Infracore and finish its restructuring program now hinge on Infracore's preferred bidder Hyundai Heavy Industries (HHI) Group, which holds the key to settling a Doosan-investor dispute over Infracore's Chinese body.
Manufacturing | 2021-01-15 17:03
Kia removes 'Motors' from its corporate name
Kia has removed “Motors” from its corporate name as the firm attempts to break away from its traditional manufacturing-driven business model, the company announced, Friday.
Auto | 2021-01-15 17:02
Why Celltrion's 'COVID treatments' unlikely be 'game changer'
Celltrion has revealed positive Phase 2 clinical trial results for its COVID-19 treatment Regkirona, also known as CT-P59, raising expectations that the firm will get conditional approval for its use here as early as this month.
Health & Welfare | 2021-01-15 10:04
  • COVID-19 cases in 500s for 6th day; tougher curbs partially eased
Samsung Biologics eyes 'multidimensional expansion' for next decade
John Rim, the new CEO of Samsung Biologics, said the company will pursue multidimensional expansion in the biopharmaceutical industry, ranging from its existing contract development and manufacturing organization (CDMO) business to developing proprietary new drugs.
Health & Welfare | 2021-01-13 23:40
 1 2345678910
WooriBank
  • Biracial Korean teacher promotes openness through education
  • International students to be included in mandatory health insurance program
  • Man gets life sentence for killing girlfriend and her sister
  • [EXCLUSIVE] Vingroup seeks to acquire LG smartphone manufacturing plants
  • Joe Biden sworn in as 46th president of the United States
  • Lotte's dwindling revenues attributed to failure to embrace innovation
  • Foreigners without face masks punished with push-ups in Bali
  • Biden takes office as 46th president [PHOTOS]
  • New virus cases in 400s for 2nd day amid downward trend
  • Questions growing over Moon's pick for foreign minister
photo news
  • Celebrating Korea-Czech relations

  • To-be-built dormitory

  • Polar vortex grips Korea [PHOTOS]

  • Tangerine tea on Jeju: A sip of comfort [PHOTOS]

Biden takes office as 46th president [PHOTOS]
WooriBank
  • About Korea Times
  • CEO Message
  • Times History
  • Content Sales
  • Media Kit
  • Contact Us
  • Location
  • Privacy Statement
  • Terms of Service
  • Mobile Service
  • RSS Service
  • Ombudsman
  • hankookilbo
  • Dongwha Group
  • Code of Ethics
Copyright